Lars Kongsbak
Direktor/Vorstandsmitglied bei VIROGATES A/S
Vermögen: 6 453 $ am 30.04.2024
Aktive Positionen von Lars Kongsbak
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIROGATES A/S | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | 01.02.2015 | - | |
Vorsitzender | 01.02.2015 | - | |
BlueBee Holding BV
BlueBee Holding BV Medical SpecialtiesHealth Technology Bluebee Holding BV engages in the development of a private cloud-based accelerated genomics platform. It supports cross-functional teams of life science researchers and clinicians by effectively centralizing and managing their genomics data processes and storage needs. The company was founded in 2011 by Vlad-Mihai Sima, Koen Bertls, Luk Wayne, and Zaid Al-Ars and is headquartered in Rijswijk, the Netherlands. | Direktor/Vorstandsmitglied | 08.05.2017 | - |
Independent Dir/Board Member | 08.05.2017 | - | |
Samplix ApS
Samplix ApS BiotechnologyHealth Technology Samplix ApS provides technology for enrichment of deoxyribonucleic acid samples. Its PINS technology enables enrichment of deoxyribonucleic acid or ribonucleic acid targets from extremely complex and low abundance samples such as environment, blood, or biopsy samples. The company was founded in 2013 and is headquartered in Herlev, Denmark. | Vorstandsvorsitzender | 01.11.2017 | - |
Präsident | 01.11.2017 | - |
Karriereverlauf von Lars Kongsbak
Ehemalige bekannte Positionen von Lars Kongsbak
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EXIQON A/S | Vorstandsvorsitzender | 01.01.2003 | 01.10.2016 |
Präsident | 01.01.2003 | 01.10.2016 |
Ausbildung von Lars Kongsbak
Technical University of Denmark | Doctorate Degree |
University of Copenhagen | Graduate Degree |
Statistik
International
Dänemark | 6 |
Niederlande | 2 |
Operativ
Chief Executive Officer | 2 |
President | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VIROGATES A/S | Health Technology |
Private Unternehmen | 3 |
---|---|
Exiqon A/S
Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Samplix ApS
Samplix ApS BiotechnologyHealth Technology Samplix ApS provides technology for enrichment of deoxyribonucleic acid samples. Its PINS technology enables enrichment of deoxyribonucleic acid or ribonucleic acid targets from extremely complex and low abundance samples such as environment, blood, or biopsy samples. The company was founded in 2013 and is headquartered in Herlev, Denmark. | Health Technology |
BlueBee Holding BV
BlueBee Holding BV Medical SpecialtiesHealth Technology Bluebee Holding BV engages in the development of a private cloud-based accelerated genomics platform. It supports cross-functional teams of life science researchers and clinicians by effectively centralizing and managing their genomics data processes and storage needs. The company was founded in 2011 by Vlad-Mihai Sima, Koen Bertls, Luk Wayne, and Zaid Al-Ars and is headquartered in Rijswijk, the Netherlands. | Health Technology |
- Börse
- Insiders
- Lars Kongsbak
- Erfahrung